This program follows two patients on their cardiovascular disease (CVD) journeys. Risk factors leading to the development and progression of atherosclerotic CVD and heart failure are discussed in the context of the patient experience over time. Strategies for primary and secondary prevention and optimization of guideline-directed medical therapy are also highlighted.

This content is developed exclusively by or on behalf of the industry sponsor through a third party and is not reviewed by Pri-Med. The content and opinions expressed are those of the sponsor or presenters and may not reflect the views of Pri-Med.



Abena Osei-Wusu, MD, FACC, FSCAI

Medical Director, Atherosclerosis 
Cardiovascular, Renal & Metabolism Medical Unit 
Novartis Pharmaceuticals Corporation


Mark Stampehl, MD, FACC, FHFSA

Executive Medical Director 
Cardiovascular, Renal & Metabolism Medical Unit 
Novartis Pharmaceuticals Corporation 


Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.